Genuardi M, Anti M, Capozzi E, Leonardi F, Fornasarig M, Novella E, Bellacosa A, Valenti A, Gasbarrini G B, Roncucci L, Benatti P, Percesepe A, Ponz de Leòn M, Coco C, de Paoli A, Valentini M, Boiocchi M, Neri G, Viel A
Institute of Medical Genetics, Facoltà di Medicina e Chirurgia A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
Int J Cancer. 1998 Mar 16;75(6):835-9. doi: 10.1002/(sici)1097-0215(19980316)75:6<835::aid-ijc4>3.0.co;2-w.
Genetic diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) may have a significant impact on the clinical management of patients and their at-risk relatives. At present, clinical criteria represent the simplest and most useful method for the identification of HNPCC families and for the selection of candidates for genetic testing. However, reports of mismatch repair (MMR) gene mutations in families not fulfilling the minimal diagnostic criteria point out the necessity to identify additional clinical parameters suggestive of genetic predisposition to colorectal cancer (CRC) related to MMR defects. We thus investigated a series of 32 Italian putative HNPCC individuals selected on the basis of one of the following criteria: 1) family history of CRC and/or other extracolonic tumors; 2) early-onset CRC; and 3) presence of multiple primary malignancies in the same individual. These patients were investigated for the presence of MLH1 and MSH2 mutations by single-strand conformation polymorphism analysis. Pathogenetic truncating mutations were identified in 4 (12.5%) cases, 3 of them involving MSH2 and 1 MLH1. In addition, 2 missense MLH1 variants of uncertain significance were observed. All pathogenetic mutations were associated with early age (<40 years) at onset and proximal CRC location. Our results support the contention that constitutional MMR mutations can also occur in individuals without the classical HNPCC pattern. Moreover, evaluation of the clinical parameters associated with MMR mutations indicates that early onset combined with CRC location in the proximal colon can be definitely considered suggestive of MMR-related hereditary CRC and should be included among the guidelines for referring patients for genetic testing.
遗传性非息肉病性结直肠癌(HNPCC)的基因诊断可能会对患者及其高危亲属的临床管理产生重大影响。目前,临床标准是识别HNPCC家族以及选择基因检测候选者的最简单且最有用的方法。然而,在不符合最低诊断标准的家族中发现错配修复(MMR)基因突变的报告指出,有必要识别出其他提示与MMR缺陷相关的结直肠癌(CRC)遗传易感性的临床参数。因此,我们对32名意大利疑似HNPCC个体进行了研究,这些个体是根据以下标准之一挑选出来的:1)有CRC和/或其他结肠外肿瘤的家族史;2)早发性CRC;3)同一个体存在多个原发性恶性肿瘤。通过单链构象多态性分析对这些患者进行MLH1和MSH2突变检测。在4例(12.5%)中鉴定出致病截短突变,其中3例涉及MSH2,1例涉及MLH1。此外,还观察到2个意义不确定的错义MLH1变异体。所有致病突变均与发病年龄早(<40岁)和近端CRC部位相关。我们的结果支持这样的观点,即遗传性MMR突变也可能发生在没有典型HNPCC模式的个体中。此外,对与MMR突变相关的临床参数的评估表明,早发性结合近端结肠的CRC部位可明确被认为提示与MMR相关的遗传性CRC,应纳入将患者转诊进行基因检测的指南中。